Noemi Reguart
Barcelona, CT 08036, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 135 publications
Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial.
Journal: Journal for immunotherapy of cancer
Published: July 08, 2026
Updates in Small Cell Lung Cancer Treatment: No Longer Too Small to Ignore-A Review of Recent Therapeutic Advances.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: June 02, 2026
ARIAN protocol: a phase III study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancer.
Journal: Expert opinion on biological therapy
Published: May 20, 2026
ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I-III small cell lung cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 17, 2026
ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I-III small cell lung cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 17, 2026
Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation.
Journal: ESMO open
Published: March 10, 2026
First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 15, 2025
Silicon-based nanopillars: a novel platform for tissue applications.
Journal: Biomaterials science
Published: November 04, 2025
Corrigendum to "Characterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study)" [Lung Cancer 206 (2025) 108677].
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 09, 2025
Antagonistic SMAD2/3 control of TIMP-1, VEGF-A, and hypoxia signaling in myofibroblasts shapes histotype-specific angiogenesis in lung cancer.
Journal: Cell death & disease
Published: September 29, 2025
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 05, 2025
Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 01, 2025
Last Updated: 09/26/2026